Mometasone Furoate Container Closure System
FDA premarket approval P100044/S030 · decided 2017-09-27
Approval details
- PMA number
- P100044
- Supplement
- S030
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- Mometasone Furoate Container Closure System
- Generic name
- Drug-eluting sinus stent
- Applicant
- Intersect Ent.
- Date received
- 2017-08-29
- Decision date
- 2017-09-27
- Days to decision
- 29 days
- Decision code
- OK30
- Product code
- OWO
- Advisory committee
- Ear, Nose, Throat
- Expedited review
- No
- Location
- Menlo Park, CA
- Statement
- Addition of automated sealing equipment to add aluminum seals to the mometasone furoate (MF) container closure system utilized to store drug in the manufacturing area.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| VenSure LightGuide (K212774) | Intersect Ent. | 2022-02-04 |